Shahab Moossavi, MD, is remembered as a "dedicated physician who made a meaningful difference in the lives of his patients and the colleagues who worked alongside him." He was 51 years old.
Remedy Robotics has developed an AI-powered robotic platform and software suite that can be used before and during endovascular procedures. The company plans on using this funding round to ramp up clinical research, deploy prototypes and more.
Patients with a Tandem Mobi insulin pump will soon be able to choose between two wear options—tubed and tubeless—with the same device. Tubeless insulin delivery can last up to seven days.
Researchers tracked data from more than 600,000 procedures, noting that 30-day outcomes for operators with less than five years of experience were comparable to those for more experienced specialists.
Researchers found that AI-generated preliminary reports were noninferior to those built by experienced sonographers and cardiologists. It is still true, however, that all final reports need to be reviewed by a trained specialist.
An FDA statement called the new approval of Bayer's asundexian a "meaningful advance for patients and healthcare providers seeking a new option for secondary stroke prevention."
Curtiss Stinis, MD, has been performing TAVR for nearly two decades. He says the new policies from CMS that expand coverage for asymptomatic patients represent a "momentous step forward" for heart patients with severe aortic stenosis.